Leaders in Learning: Publications of Faculty & Staff


Oncology 2001-2002



BATTISTA, J.J.

Chen, J.Z., J. Van Dyk, C. Lewis, and J.J. Battista. 2001. A two-source model for electron beams: calculation of relative output factors. Medical Physics 28 (8): 1735-1745.

Karnas, S.J., N. Avvakumov, E. Yu, and J.J. Battista. 2001. Operational characteristics of a prototype x-ray needle device. Physics in Medicine and Biology 46 (1): 97-106.

Karnas, S.J., VV. Moiseenko, E. Yu, P. Truong, and J.J. Battista. 2001. Monte Carlo Simulations and Measurement of DNA damage from x-ray-triggered auger cascades in iodo-deoxyuridine (IUdR). Radiation and Environmental Biophysics 40 (3): 199-206.

Moiseenko, V., S.J. Karnas, E. Yu, and J.J. Battista. 2002. Monte Carlo Simulations of DNA Damage from Incorporated Cold Iodine Following photoelectrically induced Auger electron cascades. Radiation Protection Dosimetry 99: 113-116.

Tai, P., J. Van Dyk, J. Battista, E. Yu, L. Stitt, J. Tonita, O. Agboola, J. Brierley, R. Dar, C. Leighton, S. Malone, B. Strang, P. Truong, G. Videtic, C.S. Wong, R. Wong, and Y. Youssef. 2002. Improving the consistency in cervical esophageal target volume definition by special training. International Journal of Radiation Oncology, Biology & Physics 53: 766-774.
 
 

BAUMAN, G.S.

Fisher, B.J., E. Naumova, C.C. Leighton, G.N. Naumov, N. Kerklviet, D. Fortin, D.R. Macdonald, J.G. Cairncross, G.S. Bauman, and L. Stitt. 2002. Ki-67: a prognostic factor for low-grade glioma? International Journal of Radiation Oncology, Biology & Physics 52 (4): 996-1001.

Winquist, E.W., G.S. Bauman, and J. Balogh. 2001. Nontraumatic osteonecrosis after chemotherapy for testicular cancer: A systemic review. American Journal of Clinical Oncology 24 (6): 603-606.
 
 

BRAMWELL, V.H.C.

Bramwell, V.H., D. Morris, D.S. Ernst, I. Hings, M. Blackstein, P.M. Venner, E.I. Ette, M.W. Harding, S. Waxman, and G.D. Demetri. 2002. Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma. Clinical Cancer Research 8 (2): 383-393.

Furger, K.A., R.K. Menon, A.B. Tuck, V.H. Bramwell, and A.F. Chambers. 2001. The functional and clinical roles of osteopontin in cancer and metastasis. Current Molecular Medicine 1 (5): 621-632.

Gortzak, E., A. Azzarelli, J. Buesa, V.H.C. Bramwell, F. van Coevorden, A.N. van Geel, A. Ezzat, A. Santoro, J.W. Oosterhuis, N. van Glabbeke, A. Kirkpatrick, J. Verweij, and The E.O.R.T.C. Soft Tissue Bone Sarcoma Group and the National Cancer Institute of Canada Clinical Trials. 2001. A randomised phase II study on neo-adjuvant chemotherapy for "high risk" adult soft tissue sarcoma. European Journal of Cancer 37 (9): 1096-1103.

O'Sullivan, B., R. Bell, and V. Bramwell. 2002. Sarcoma of the soft tissues (Chapter 16.1). Oxford Textbook of Oncology. 2nd ed. R.L. Souhami, I. Tannock, and P. Hohenberger. Oxford: Oxford University Press. 2495-2523.

Verma, S., and V. Bramwell. 2002. Dose-intensive chemotherapy in advanced adult soft tissue sarcoma. Expert Review of Anticancer Therapy 2 (2): 201-215.

Winquist, E., V. Bramwell, and T. Vandenberg. 2002. Anastrazole versus tamoxifen as first-line therapy for advanced breast cancer: methodologic issues. Journal of Clinical Oncology 20 (17): 3748-3750.
 
 

CAIRNCROSS, J.G.

Betensky, R.A., D.N. Louis, and J.G. Cairncross. 2002. Influence of unrecognized molecular heterogeneity on randomized clinical trials. Journal of Clinical Oncology 20 (10): 2495-2499.

DeAngelis, L.M., and J.G. Cairncross. 2002. A better way to find tumor in the CSF? Neurology 58 (3): 339-340.

Fisher, B.J., E. Naumova, C.C. Leighton, G.N. Naumov, N. Kerklviet, D. Fortin, D.R. Macdonald, J.G. Cairncross, G.S. Bauman, and L. Stitt. 2002. Ki-67: a prognostic factor for low-grade glioma? International Journal of Radiation Oncology, Biology & Physics 52 (4): 996-1001.

Fortin, D., D.R. Macdonald, L. Stitt, and J.G. Cairncross. 2001. PCV for oligodendroglial tumors: in search of prognostic factors for response and survival. The Canadian Journal of Neurological Sciences 28 (3): 215-223.

Li, Y., R.A. Betensky, D.N. Louis, and J.G. Cairncross. 2002. The use of frailty hazard models for unrecognized heterogeneity that interacts with treatment: considerations of efficiency and power. Biometrics 58 (1): 232-236.

Louis, D.N., E.C. Holland, and J.G. Cairncross. 2001. Glioma classification: a molecular reappraisal. American Journal of Pathology 159 (3): 779-786.

Louis, D.N., S.L. Pomeroy, and J.G. Cairncross. 2002. Focus on central nervous system neoplasia. Cancer Cell 1 (2): 125-128.

Sasaki, H., R.A. Betensky, J.G. Cairncross, and D.N. Louis. 2002. DMBT1 polymorphisms: relationship to malignant glioma tumorigenesis. Cancer Research 62 (6): 1790-1796.

Sasaki, H., M.C. Zlatescu, R.A. Betensky, Y. Ino, J.G. Cairncross, and D.N. Louis. 2001. PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis. American Journal of Pathology 159 (1): 359-367.

Sasaki, H., M.C. Zlatescu, R.A. Betensky, L.B. Johnk, A.N. Cutone, J.G. Cairncross, and D.N. Louis. 2002. Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma". Journal of Neuropathology and Experimental Neurology 61 (1): 58-63.

Zlatescu, M.C., A. TehraniYazdi, H. Sasaki, J.-F. Megyesi, R.A. Betensky, D.N. Louis, and J.G. Cairncross. 2001. Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Research 61 (18): 6713-6715.
 
 

CHAMBERS, A.F.

Agrawal, D., T. Chen, R. Irby, J. Quackenbush, A.F. Chambers, M. Szabo, A. Cantor, D. Coppola, and T.J. Yeatman. 2002. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. Journal of the National Cancer Institute 94 (7): 513-521.

Apparao, K.B., M.J. Murray, M.A. Fritz, W.R. Meyer, A.F. Chambers, P.R. Truong, and B.A. Lessey. 2001. Osteopontin and its receptor alphavbeta(3) integrin are co-expressed in the human endometrium during the menstrual cycle byt regulated differentially. Journal of Clinical Endocrinology and Metabolism 86 (10): 4991-5000.

Furger, K.A., R.K. Menon, A.B. Tuck, V.H. Bramwell, and A.F. Chambers. 2001. The functional and clinical roles of osteopontin in cancer and metastasis. Current Molecular Medicine 1 (5): 621-632.

Kon, S., Y. Yokosaki, M. Maeda, T. Segawa, Y. Horikoshi, H. Tsukagoshi, M.M. Rashid, J. Morimoto, M. Inobe, N. Shijubo, A.F. Chambers, and T. Uede. 2002. Mapping of functional epitopes of osteopontin by monoclonal antibodies raised against defined internal sequences. Journal of Cellular Biochemistry 84 (2): 420-432.

Naumov, G.N., I. MacDonald, P.M. Weinmeister, N. Kerkvliet, K.V. Nadkarni, S.M. Wilson, V.L. Morris, A.C. Groom, and A.F. Chambers. 2002. Persistence of solitary mammary carcinoma cells in a secondary site: Possible contributor to dormancy. Cancer Research 62 (7): 2162-2168.

Tuck, A.B., and A.F. Chambers. 2001. The role of osteopontin in breast cancer: Clinical and experimental studies. Journal of Mammary Gland Biology and Neoplasia 6 (4): 419-429.

Tuck, A.B., C. Hota, and A.F. Chambers. 2001. Osteopontin (OPN)-induced increase in human mammary epithelial cell invasiveness is urokinase (uPA)-dependent. Breast Cancer Research and Treatment 70 (3): 197-204.

Varghese, H.J., M.T. Davidson, I.C. MacDonald, S.M. Wilson, K.V. Nadkarni, A.C. Groom, and A.F. Chambers. 2002. Activated ras regulates the proliferation/apoptosis balance and early survival of developing micrometastases. Cancer Research 62 (3): 887-891.
 
 

CHEN, J.Z.

Chen, J.Z., J. Van Dyk, C. Lewis, and J.J. Battista. 2001. A two-source model for electron beams: calculation of relative output factors. Medical Physics 28 (8): 1735-1745.

Wong, E., J. Chen, and J. Greenland. 2002. Intensity-modulated arc therapy simplified. International Journal of Radiation Oncology, Biology & Physics 53 (1): 222-235.
 
 

DAR, A.R.

Bedard, E.L., R.I. Inculet, R.A. Malthaner, E. Brecevic, M. Vincent, and R. Dar. 2001. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma. Cancer 91 (12): 2423-2430.

Tai, P., J. Van Dyk, J. Battista, E. Yu, L. Stitt, J. Tonita, O. Agboola, J. Brierley, R. Dar, C. Leighton, S. Malone, B. Strang, P. Truong, G. Videtic, C.S. Wong, R. Wong, and Y. Youssef. 2002. Improving the consistency in cervical esophageal target volume definition by special training. International Journal of Radiation Oncology, Biology & Physics 53: 766-774.

Videtic, G.M., K. Fung, A.T. Tomiak, L.W. Stitt, A.R. Dar, P.T. Truong, E.W. Yu, M.D. Vincent, and W.I. Kocha. 2001. Using treatment interruptions ot palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer lung cancer decreases survival and disease control. Lung Cancer 33 (2-3): 249-258.
 
 

DIMATTIA, G.E.

Groves, T.C., G.F. Wagner, and G.E. DiMattia. 2001. cAMP signaling can antagonize potent glucocorticoid post-transcriptional inhibition of stanniocalcin gene expression. Journal of Endocrinology 171 (3): 499-516.

McCudden, C.R., M.R. Kogon, G.E. DiMattia, and G.F. Wagner. 2001. Novel expression of the stanniocalcin gene in fish. Journal of Endocrinology 171 (1): 33-44.

Varghese, R., A.D. Gagliardi, P.E. Bialek, S.P. Yee, G.F. Wagner, and G.E. DiMattia. 2002. Overexpression of human stanniocalcin affects growth and reproduction in transgenic mice. Endocrinology 143 (3): 868-876.

Wong, C.K., H.Y. Yeung, N.K. Mak, G.E. DiMattia, D.K. Chan, and G.F. Wagner. 2002. Effects of dibutyryl cAMP on stanniocalcin and stanniocalcin-related protein mRNA expression in neuroblastoma cells. Journal of Endocrinology 173 (1): 199-209.
 
 

FISHER, B.J.

Endicott, T.J., B.J. Fisher, E. Wong, N.A. Paterson, L.E. Gaspar, and M. Bauman. 2001. Pulmonary sequelae after electron spinal irradiation. Radiotherapy and Oncology 60 (3): 267-272.

Fisher, B.J., C.C. Leighton, O. Vujovic, D.R. Macdonald, and L. Stitt. 2001. Results of a policy of surveillance alone after surgical management of pediatric low-grade gliomas. International Journal of Radiation Oncology, Biology & Physics 51 (3): 704-710.

Fisher, B.J., E. Naumova, C.C. Leighton, G.N. Naumov, N. Kerklviet, D. Fortin, D.R. Macdonald, J.G. Cairncross, G.S. Bauman, and L. Stitt. 2002. Ki-67: a prognostic factor for low-grade glioma? International Journal of Radiation Oncology, Biology & Physics 52 (4): 996-1001.

Fisher, B.J., C. Scott, D.R. Macdonald, C. Coughlin, and W.J. Curran. 2001. Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: Results of Radiation Therapy Oncology Group Trial 9507. Journal of Clinical Oncology 19 (4): 1111-1117.
 
 

JORDAN, K.

Munro, P., K. Jordan, C. Lewis, and T. Heerema. 2001. Technique charts for EC film: direct optical measurements to account for the effects of X-ray scatter. International Journal of Radiation Oncology, Biology & Physics 50 (3): 829-836.
 
 

KOCHA, W.I.

Tomiak, A., M. Vincent, C.C. Earle, P.G. Johnston, W. Kocha, M. Taylor, J. Maroun, L. Eidus, F. Whiston, and L. Stitt. 2001. Thymidylate synthase expression in stage II and III colon cancer: A retrospective review. American Journal of Clinical Oncology 24 (6): 597-602.

Videtic, G.M., K. Fung, A.T. Tomiak, L.W. Stitt, A.R. Dar, P.T. Truong, E.W. Yu, M.D. Vincent, and W.I. Kocha. 2001. Using treatment interruptions ot palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer lung cancer decreases survival and disease control. Lung Cancer 33 (2-3): 249-258.
 
 

KOROPATNICK, D.J.

Berg, R.W., M. Werner, P.J. Ferguson, C. Postenka, M. Vincent, D.J. Koropatnick, and E. Behrend. 2001. Tumor growth inhibition in vivo and G(2)/M cell cycle arrest induced by antisense oligodeoxynucleotide targeting thymidylate synthase. Journal of Pharmacology Experimental Therapy 298 (2): 477-484.

Cai, L., J. Koropatnick, and M.G. Cherian. 2001. Roles of vitamin C in radiation-induced DNA damage in presence and absence of copper. Chemico-Biological Interactions 137 (1): 75-88.

Czachor, J.D., M.G. Cherian, and J. Koropatnick. 2002. Reduction of copper and metallothionein in toxic milk mice by tetrathiomolybdate, but not deferiprone. Journal of Inorganic Biochemistry 88 (2): 213-222.

DeMoor, J.M., W.A. Kennette, O.M. Collins, and J. Koropatnick. 2001. Zinc-metallothionein levels are correlated with enhanced glucocorticoid responsiveness in mouse cells exposed to ZnCl(2), HgCl(2), and heat shock. Toxicological Sciences 64 (1): 67-76.

Ferguson, P.J., J.M. DeMoor, M.D. Vincent, and J. Koropatnick. 2001. Antisense-induced down-regulation of thymidylate synthase and enhanced cytotoxicity of 5-FUdR in 5-FUdR-resistant HeLa cells. British Journal of Pharmacology 134 (7): 1437-1446.
 
 

KRON, T.

Howlett, S.J., and T. Kron. 2002. Monitor unit calculation for tangential breast treatments: verification in an anthropomorphic phantom. Journal Applied Clinical Medical Physics 3 (3): 235-240.

Jeraj, R., A. Sarvary, and T. Kron. 2002. Optimal flattening filter shape of a surface brachytherapy applicator. Physics in Medicine and Biology 47 (5): 723-735.

Kron, T., C. Hamilton, M. Roff, and J. Denham. 2002. Dosimetric intercomparison for two Australasian clinical trials using an anthropomorphic phantom. International Journal of Radiation Oncology, Biology & Physics 52 (2): 566-579.

Kron, T., M. Haque, K. Foulke, and R. Jeraj. 2002. A flattening filter for brachytherapy skin irradiation. Physics in Medicine and Biology 47 (5): 713-722.
 
 

LEIGHTON, CC.

Fisher, B.J., C.C. Leighton, O. Vujovic, D.R. Macdonald, and L. Stitt. 2001. Results of a policy of surveillance alone after surgical management of pediatric low-grade gliomas. International Journal of Radiation Oncology, Biology & Physics 51 (3): 704-710.

Fisher, B.J., E. Naumova, C.C. Leighton, G.N. Naumov, N. Kerklviet, D. Fortin, D.R. Macdonald, J.G. Cairncross, G.S. Bauman, and L. Stitt. 2002. Ki-67: a prognostic factor for low-grade glioma? International Journal of Radiation Oncology, Biology & Physics 52 (4): 996-1001.

Leighton, C.C., and D.T. Shum. 2001. Osteoclastic giant cell tumor of the pancreas: case report and literature review. American Journal of Clinical Oncology 24 (1): 77-80.

Tai, P., J. Van Dyk, J. Battista, E. Yu, L. Stitt, J. Tonita, O. Agboola, J. Brierley, R. Dar, C. Leighton, S. Malone, B. Strang, P. Truong, G. Videtic, C.S. Wong, R. Wong, and Y. Youssef. 2002. Improving the consistency in cervical esophageal target volume definition by special training. International Journal of Radiation Oncology, Biology & Physics 53: 766-774.
 
 

LEWIS, C.

Chen, J.Z., J. Van Dyk, C. Lewis, and J.J. Battista. 2001. A two-source model for electron beams: calculation of relative output factors. Medical Physics 28 (8): 1735-1745.

Munro, P., K. Jordan, C. Lewis, and T. Heerema. 2001. Technique charts for EC film: direct optical measurements to account for the effects of X-ray scatter. International Journal of Radiation Oncology, Biology & Physics 50 (3): 829-836.
 
 

MACDONALD, D.R.

Fisher, B.J., C.C. Leighton, O. Vujovic, D.R. Macdonald, and L. Stitt. 2001. Results of a policy of surveillance alone after surgical management of pediatric low-grade gliomas. International Journal of Radiation Oncology, Biology & Physics 51 (3): 704-710.

Fisher, B.J., E. Naumova, C.C. Leighton, G.N. Naumov, N. Kerklviet, D. Fortin, D.R. Macdonald, J.G. Cairncross, G.S. Bauman, and L. Stitt. 2002. Ki-67: a prognostic factor for low-grade glioma? International Journal of Radiation Oncology, Biology & Physics 52 (4): 996-1001.

Fisher, B.J., C. Scott, D.R. Macdonald, C. Coughlin, and W.J. Curran. 2001. Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: Results of Radiation Therapy Oncology Group Trial 9507. Journal of Clinical Oncology 19 (4): 1111-1117.
 
 

MYMRYK, J.S.

Avvakumov, N., and J.S. Mymryk. 2002. New tools for the construction of replication-competent adenoviral vectors with altered E1A regulation. Journal of Virological Methods 103 (1): 41-49.

Avvakumov, N., M. Sahbegovic, Z. Zhang, M. Shuen, and J.S. Mymryk. 2002. Analysis of DNA binding by the adenovirus type 5 E1A oncoprotein. Journal of General Virology 83 (Pt 3): 517-524.

Frisch, S.M., and J.S. Mymryk. 2002. Adenovirus-5 E1A: paradox and paradigm. Nature Reviews. Molecular Cell Biology 3 (6): 441-452.

Zhang, Z., M.M. Smith, and J.S. Mymryk. 2001. Interaction of the E1A oncoprotein with Yak1p, a novel regulator of yeast pseudohyphal differentiation, and related mammalian kinases. Molecular Biology of the Cell 12 (3): 699-710.
 
 

RODRIGUES, GB.

Brierley, J.D., P.A. Catton, B. O'Sullivan, J.E. Dancey, A.J. Dowling, J.C. Irish, T.S. McGowan, J.F. Sturgeon, C.J. Swallow, G.B. Rodrigues, and T. Panzarella. 2002. Accuracy of recorded tumor, node, and metastasis stage in a comprehensive cancer center . Journal of Clinical Oncology 20 (2): 413-9.
 
 

TORCHIA, J.

Beischlag, T.V., S. Wang, D.W. Rose, J. Torchia, S. Reisz-Porszasz, K. Muhammad, W. Nelson, M.R. Probst, M.G. Rosenfeld, and O. Hankinson. 2002. Recruitment of the NCoA/SRC-1/p160 family of transcriptional coactivators by the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator complex. Molecular and Cellular Biology 22 (12): 4319-4333.

Tini, M., A. Benecke, S.J. Um, J. Torchia, R.M. Evans, and P. Chambon. 2002. Association of CBP/p300 acetylase and thymine DNA glycosylase links DNA repair and transcription. Molecular Cell 9 (2): 265-277.
 
 

TURLEY, E.A.

Harrison, R.E., and E.A. Turley. 2001. Active erk regulates microtubule stability in H-ras-transformed cells. Neoplasia 3 (5): 385-394.

Lynn, B.D., X. Li, P.A. Cattini, E.A. Turley, and J.I. Nagy. 2001. Identification of sequence, protein isoforms and distribution of the hyaluronan-binding protein RHAMM in adult and developing rat brain. Journal of Comparative Neurology 439 (3): 315-330.

Lynn, B.D., E.A. Turley, and J.I. Nagy. 2001. Subcellular distribution, calmodulin interaction, and mitochondrial association of the hyaluronan-binding protein RHAMM in rat brain. Journal of Neuroscience Research 65 (1): 6-16.

Tammi, M.I., A.J. Day, and E.A. Turley. 2002. Hyaluronan and homeostasis: a balancing act. Journal of Biological Chemistry 277 (7): 4581-4584.

Turley, E.A., P.W. Noble, and L.Y. Bourguigon. 2002. Signaling properties of hyaluronan receptors. Journal of Biological Chemistry 277 (7): 4589-4592.

Ziebell, M.R., Z.G. Zhao, B. Luo, Y. Luo, E.A. Turley, and G.D. Prestwich. 2001. Peptides that mimic glycosaminoglycans: high-affinity ligands for a hyaluronic binding domain. Chemistry & Biology 8 (11): 1081-1094.
 
 

VAN DYK, J.

Chen, J.Z., J. Van Dyk, C. Lewis, and J.J. Battista. 2001. A two-source model for electron beams: calculation of relative output factors. Medical Physics 28 (8): 1735-1745.

Tai, P., J. Van Dyk, J. Battista, E. Yu, L. Stitt, J. Tonita, O. Agboola, J. Brierley, R. Dar, C. Leighton, S. Malone, B. Strang, P. Truong, G. Videtic, C.S. Wong, R. Wong, and Y. Youssef. 2002. Improving the consistency in cervical esophageal target volume definition by special training. International Journal of Radiation Oncology, Biology & Physics 53: 766-774.
 
 

VANDENBERG, T.

Winquist, E., V. Bramwell, and T. Vandenberg. 2002. Anastrazole versus tamoxifen as first-line therapy for advanced breast cancer: methodologic issues. Journal of Clinical Oncology 20 (17): 3748-3750.
 
 

VIDETIC, G.M.

Videtic, G.M., K. Fung, A.T. Tomiak, L.W. Stitt, A.R. Dar, P.T. Truong, E.W. Yu, M.D. Vincent, and W.I. Kocha. 2001. Using treatment interruptions ot palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer lung cancer decreases survival and disease control. Lung Cancer 33 (2-3): 249-258.

Videtic, G.M., L.E. Gaspar, L. Zamorano, L.W. Stitt, J. Fontanesi, and K.J. Levin. 2001. Implant volume as a prognostic variable in brachytherapy decision-making for malignant gliomas stratified by the RTOG recursive partitioning analysis. International Journal of Radiation Oncology, Biology & Physics 51 (4): 963-968.
 
 

VINCENT, M.D.

Bedard, E.L., R.I. Inculet, R.A. Malthaner, E. Brecevic, M. Vincent, and R. Dar. 2001. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma. Cancer 91 (12): 2423-2430.

Berg, R.W., M. Werner, P.J. Ferguson, C. Postenka, M. Vincent, D.J. Koropatnick, and E. Behrend. 2001. Tumor growth inhibition in vivo and G(2)/M cell cycle arrest induced by antisense oligodeoxynucleotide targeting thymidylate synthase. Journal of Pharmacology Experimental Therapy 298 (2): 477-484.

Ferguson, P.J., J.M. DeMoor, M.D. Vincent, and J. Koropatnick. 2001. Antisense-induced down-regulation of thymidylate synthase and enhanced cytotoxicity of 5-FUdR in 5-FUdR-resistant HeLa cells. British Journal of Pharmacology 134 (7): 1437-1446.

Tomiak, A., M. Vincent, C.C. Earle, P.G. Johnston, W. Kocha, M. Taylor, J. Maroun, L. Eidus, F. Whiston, and L. Stitt. 2001. Thymidylate synthase expression in stage II and III colon cancer: A retrospective review. American Journal of Clinical Oncology 24 (6): 597-602.

Videtic, G.M., K. Fung, A.T. Tomiak, L.W. Stitt, A.R. Dar, P.T. Truong, E.W. Yu, M.D. Vincent, and W.I. Kocha. 2001. Using treatment interruptions ot palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer lung cancer decreases survival and disease control. Lung Cancer 33 (2-3): 249-258.
 
 

VUJOVIC, O.

Fisher, B.J., C.C. Leighton, O. Vujovic, D.R. Macdonald, and L. Stitt. 2001. Results of a policy of surveillance alone after surgical management of pediatric low-grade gliomas. International Journal of Radiation Oncology, Biology & Physics 51 (3): 704-710.
 
 

WINQUIST, E.

Winquist, E., V. Bramwell, and T. Vandenberg. 2002. Anastrazole versus tamoxifen as first-line therapy for advanced breast cancer: methodologic issues. Journal of Clinical Oncology 20 (17): 3748-3750.

Winquist, E.W., G.S. Bauman, and J. Balogh. 2001. Nontraumatic osteonecrosis after chemotherapy for testicular cancer: A systemic review. American Journal of Clinical Oncology 24 (6): 603-606.
 
 

WONG, E.

Endicott, T.J., B.J. Fisher, E. Wong, N.A. Paterson, L.E. Gaspar, and M. Bauman. 2001. Pulmonary sequelae after electron spinal irradiation. Radiotherapy and Oncology 60 (3): 267-272.

Wong, E., J. Chen, and J. Greenland. 2002. Intensity-modulated arc therapy simplified. International Journal of Radiation Oncology, Biology & Physics 53 (1): 222-235.
 
 

YEE, S.P.

Varghese, R., A.D. Gagliardi, P.E. Bialek, S.P. Yee, G.F. Wagner, and G.E. DiMattia. 2002. Overexpression of human stanniocalcin affects growth and reproduction in transgenic mice. Endocrinology 143 (3): 868-876.
 
 

YU, E.

Karnas, S.J., N. Avvakumov, E. Yu, and J.J. Battista. 2001. Operational characteristics of a prototype x-ray needle device. Physics in Medicine and Biology 46 (1): 97-106.

Karnas, S.J., VV. Moiseenko, E. Yu, P. Truong, and J.J. Battista. 2001. Monte Carlo Simulations and Measurement of DNA damage from x-ray-triggered auger cascades in iodo-deoxyuridine (IUdR). Radiation and Environmental Biophysics 40 (3): 199-206.

Moiseenko, V., S.J. Karnas, E. Yu, and J.J. Battista. 2002. Monte Carlo Simulations of DNA Damage from Incorporated Cold Iodine Following photoelectrically induced Auger electron cascades. Radiation Protection Dosimetry 99: 113-116.

Tai, P., J. Van Dyk, J. Battista, E. Yu, L. Stitt, J. Tonita, O. Agboola, J. Brierley, R. Dar, C. Leighton, S. Malone, B. Strang, P. Truong, G. Videtic, C.S. Wong, R. Wong, and Y. Youssef. 2002. Improving the consistency in cervical esophageal target volume definition by special training. International Journal of Radiation Oncology, Biology & Physics 53: 766-774.

Videtic, G.M., K. Fung, A.T. Tomiak, L.W. Stitt, A.R. Dar, P.T. Truong, E.W. Yu, M.D. Vincent, and W.I. Kocha. 2001. Using treatment interruptions ot palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer lung cancer decreases survival and disease control. Lung Cancer 33 (2-3): 249-258.